Skip to main content
. 1999 Dec 21;96(26):14894–14898. doi: 10.1073/pnas.96.26.14894

Table 3.

Serum levels of GHRH in tumor-free nude mice and nude mice bearing xenografts of H-69 SCLC treated with GHRH antagonist JV-1-36 at doses of 20 μg/day or 10 μg/day per animal

Mice GHRH, ng/ml
Tumor-free 4.75 ± 0.63
H-69-bearing
 Control 9.2  ± 1.45
 JV-1-36 (10 μg/day) 10.63 ± 1.05
 JV-1-36 (20 μg/day) 5.49 ± 0.61